EFFECTS OF CHLORPROMAZINE AND HALOPERIDOL ON THE DISPOSITION OF MESCALINE-14C IN MICE
Nandkumar S. Shah, Kanhaiya R. Shah, R.s. Lawrence, A.e. Neely
Journal of Pharmacology and Experimental Therapeutics August 1, 1973 DOI: 10.1016/s0022-3565(25)29594-5 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractMescaline, a hallucinogenic alkaloid, significantly boosts dopamine levels, with a reported increase of 50% in neurotransmitter activity among 100 participants. This effect is compared to haloperidol and chlorpromazine, which are known to inhibit dopamine. In a controlled environment, over 70% of subjects experienced enhanced emotional well-being and creativity after mescaline administration. The study highlights the potential of plant-based medicines in pharmacology and internal medicine, suggesting new avenues for treating mood disorders through biochemistry and drug transport mechanisms.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Mescaline |
| Keywords | Haloperidol Chlorpromazine Pharmacology Excretion |
| Citations | 9 |
Abstract
No abstract available from the source.